Skip to content
Disclosery

EXANE DERIVATIVES: FIS position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on FIS, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 3,436 FIS shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 3,436 shares
    Change vs previous 13F -32 shares

    0.18% of the 13F portfolio, value $314,914.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 3,468 shares
    Change vs previous 13F 0 shares

    0.1% of the 13F portfolio, value $348,235.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 3,468 shares
    Change vs previous 13F -7,804 shares

    0.09% of the 13F portfolio, value $378,518.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 11,272 shares
    Change vs previous 13F +267 shares

    0.34% of the 13F portfolio, value $1,371,528.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 11,005 shares
    Change vs previous 13F +13 shares

    0.38% of the 13F portfolio, value $1,609,224.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 10,992 shares
    Change vs previous 13F +3,510 shares

    0.47% of the 13F portfolio, value $1,545,517.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 7,482 shares
    Change vs previous 13F +6,991 shares

    0.32% of the 13F portfolio, value $1,058,355.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 491 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $72,276.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).